Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy
| Image |  |
|---|---|
| Description | scientific article published on 05 March 2020 |
| Author/s |
author: Chia-Lin Tseng |
| Publication date | March 5, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |